These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26093623)

  • 1. Case report: MR imaging features of disseminated uterine leiomyosarcoma presenting after hysterectomy with morcellation.
    Ciszak T; Mittal PK; Sullivan P; Cardona K; Hanley KZ; Khanna N; Moreno CC
    Abdom Imaging; 2015 Oct; 40(7):2600-5. PubMed ID: 26093623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Power morcellation-induced dissemination of sarcomatous component arising in leiomyoma.
    Emoto I; Moriuchi K; Kanbayashi S; Inohaya A; Ri Y; Sato Y
    J Obstet Gynaecol Res; 2018 Sep; 44(9):1843-1849. PubMed ID: 29974551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Undetected Cancer at the Time of Laparoscopic Supracervical Hysterectomy and Laparoscopic Myomectomy: Implications for the Use of Power Morcellation.
    Perkins RB; Handal-Orefice R; Hanchate AD; Lin M; Paasche-Orlow MK
    Womens Health Issues; 2016; 26(1):21-6. PubMed ID: 26701205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACOG Committee Opinion No. 770: Uterine Morcellation for Presumed Leiomyomas.
    Obstet Gynecol; 2019 Mar; 133(3):e238-e248. PubMed ID: 30801477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contained morcellation using the GelPOINT advance access platforms and 3M Steri-Drape endobag.
    Kujansuu S; Salari BW; Galloway M; Findley A; Yaklic JL; Massengill JC; Lindheim SR
    Fertil Steril; 2015 May; 103(5):e36. PubMed ID: 25772767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Morcellation Debate: The History and the Science.
    Adelman MR
    Clin Obstet Gynecol; 2015 Dec; 58(4):710-7. PubMed ID: 26512438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Power Morcellation of Unsuspected High-grade Leiomyosarcoma Within an Inflated Containment Bag: 2-year Follow-up.
    Boruta DM; Shibley T
    J Minim Invasive Gynecol; 2016; 23(6):1009-11. PubMed ID: 27393286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma.
    George S; Barysauskas C; Serrano C; Oduyebo T; Rauh-Hain JA; Del Carmen MG; Demetri GD; Muto MG
    Cancer; 2014 Oct; 120(20):3154-8. PubMed ID: 24923260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexpected Uterine Leiomyosarcoma During Laparoscopic Hysterectomy Treated 6¬†Months With Ulipristal Acetate and Contained Power Morcellation.
    Istre O
    J Minim Invasive Gynecol; 2017 Feb; 24(2):198. PubMed ID: 27539216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic hysterectomy with morcellation vs abdominal hysterectomy for presumed fibroids: an updated decision analysis following the 2014 Food and Drug Administration safety communications.
    Siedhoff MT; Doll KM; Clarke-Pearson DL; Rutstein SE
    Am J Obstet Gynecol; 2017 Mar; 216(3):259.e1-259.e6. PubMed ID: 27890646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of tumor fragmentation in patients with stage I uterine leiomyosarcoma on patterns of recurrence and oncologic outcome.
    Pedra Nobre S; Hensley ML; So M; Zhou QC; Iasonos A; Leitao MM; Ducie J; Chiang S; Mueller JJ; Abu-Rustum NR; Zivanovic O
    Gynecol Oncol; 2021 Jan; 160(1):99-105. PubMed ID: 33158511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disseminated Peritoneal Leiomyomatosis Status Post Laparoscopic Hysterectomy with Morcellation.
    Anand N; Handler M; Khan A; Wagreich A; Calhoun S
    J Radiol Case Rep; 2016 Dec; 10(12):12-18. PubMed ID: 28580061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morcellation of occult uterine malignancies: an Australian single institution retrospective study.
    Tan A; Salfinger S; Tan J; Cohen P
    Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):503-6. PubMed ID: 26314239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma.
    Park JY; Park SK; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2011 Aug; 122(2):255-9. PubMed ID: 21565389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inefficiency of ulipristal acetate on uterus leiomyomas as an additional sign to suspect leiomyosarcoma.
    Kadhel P; Smail M; Borja De Mozota D
    J Gynecol Obstet Hum Reprod; 2017 Sep; 46(7):609-611. PubMed ID: 28647614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-of-1 Policymaking--Tragedy, Trade-offs, and the Demise of Morcellation.
    Rosenbaum L
    N Engl J Med; 2016 Mar; 374(10):986-90. PubMed ID: 26962735
    [No Abstract]   [Full Text] [Related]  

  • 17. A medical-legal review of power morcellation in the face of the recent FDA warning and litigation.
    Ton R; Kilic GS; Phelps JY
    J Minim Invasive Gynecol; 2015; 22(4):564-72. PubMed ID: 25623369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the Future of Open Intraperitoneal Power-Morcellation of Fibroids?
    Parker WH; Pritts EA; Olive DL
    Clin Obstet Gynecol; 2016 Mar; 59(1):73-84. PubMed ID: 26670834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine leiomyosarcoma - incidence, treatment, and the impact of morcellation. A nationwide cohort study.
    Skorstad M; Kent A; Lieng M
    Acta Obstet Gynecol Scand; 2016 Sep; 95(9):984-90. PubMed ID: 27223683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk, risk reduction and management of occult malignancy diagnosed after uterine morcellation: a commentary.
    Lynam S; Young L; Morozov V; Rao G; Roque DM
    Womens Health (Lond); 2015 Nov; 11(6):929-44. PubMed ID: 26673851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.